Morgan Stanley Reaffirms “Equal Weight” Rating for Vital Farms (NASDAQ:VITL)

Vital Farms (NASDAQ:VITL)‘s stock had its “equal weight” rating reaffirmed by research analysts at Morgan Stanley in a note issued to investors on Friday, MarketBeat reports. They presently have a $24.00 target price on the stock, down from their previous target price of $45.00. Morgan Stanley’s price objective indicates a potential upside of 13.80% from the stock’s previous close.

Several other analysts have also issued reports on VITL. Needham & Company LLC reiterated a “buy” rating and set a $45.00 price target on shares of Vital Farms in a research report on Friday, January 30th. Zacks Research lowered Vital Farms from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 14th. Jefferies Financial Group reissued a “buy” rating and set a $52.00 price target on shares of Vital Farms in a report on Wednesday, December 17th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Vital Farms in a research note on Monday, December 29th. Finally, Mizuho decreased their target price on Vital Farms from $53.00 to $48.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 26th. Nine investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Vital Farms has an average rating of “Moderate Buy” and an average price target of $46.64.

Vital Farms Stock Performance

NASDAQ:VITL opened at $21.09 on Friday. The company has a market cap of $944.41 million, a price-to-earnings ratio of 14.65 and a beta of 1.10. Vital Farms has a fifty-two week low of $19.80 and a fifty-two week high of $53.13. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.15 and a current ratio of 2.65. The stock has a fifty day moving average price of $28.60 and a 200-day moving average price of $36.06.

Vital Farms (NASDAQ:VITL) last posted its quarterly earnings results on Thursday, February 26th. The company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.03). The company had revenue of $213.55 million during the quarter, compared to analyst estimates of $212.83 million. Vital Farms had a net margin of 8.73% and a return on equity of 21.38%. The firm’s revenue for the quarter was up 28.6% compared to the same quarter last year. During the same period last year, the firm earned $0.23 EPS. As a group, equities analysts anticipate that Vital Farms will post 1.11 EPS for the current fiscal year.

Insider Transactions at Vital Farms

In other Vital Farms news, insider Matthew Ohayer sold 25,000 shares of the stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $30.85, for a total value of $771,250.00. Following the completion of the transaction, the insider directly owned 6,361,190 shares in the company, valued at approximately $196,242,711.50. This trade represents a 0.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Russell Diez-Canseco sold 16,734 shares of Vital Farms stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $35.05, for a total value of $586,526.70. Following the sale, the chief executive officer directly owned 649,684 shares in the company, valued at $22,771,424.20. The trade was a 2.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 91,734 shares of company stock valued at $2,921,477. Insiders own 21.30% of the company’s stock.

Hedge Funds Weigh In On Vital Farms

Several institutional investors and hedge funds have recently added to or reduced their stakes in VITL. Royal Bank of Canada lifted its holdings in shares of Vital Farms by 89.2% during the first quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock worth $591,000 after purchasing an additional 9,136 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Vital Farms by 5.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock worth $611,000 after purchasing an additional 1,108 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Vital Farms by 3.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock worth $12,658,000 after buying an additional 13,397 shares during the period. Woodline Partners LP bought a new stake in shares of Vital Farms in the 1st quarter valued at about $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Vital Farms by 1.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock valued at $2,739,000 after buying an additional 1,198 shares during the period. 98.59% of the stock is currently owned by institutional investors and hedge funds.

Key Vital Farms News

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Q4 revenue growth and top‑line clarity — Revenue rose ~28.6% year‑over‑year and Q4 revenue came in essentially inline with expectations, showing continued demand and scale benefits. This supports the company’s growth story even though EPS missed. MarketBeat / Press Release
• Neutral Sentiment: Board leadership transition — Founder Matt O’Hayer stepped down as Executive Chair; CEO Russell Diez‑Canseco was named Executive Chair to maintain continuity. This reduces governance uncertainty short‑term but is unlikely to change fundamentals immediately. Business Wire
• Negative Sentiment: EPS miss and mixed guidance reaction — Q4 EPS of $0.35 missed the $0.38 consensus (revenues roughly inline). Several outlets highlight the profit shortfall and guidance interpretation that disappointed some investors, which directly pressured the stock. Zacks
• Negative Sentiment: Securities‑class investigation announced — The Rosen Law Firm has opened an investigation alleging Vital Farms may have provided materially misleading information to investors. Such filings often increase short‑term selling pressure and can raise legal risk and potential future costs. GlobeNewswire
• Negative Sentiment: Analyst revisions and target cuts — Multiple firms updated coverage: Benchmark downgraded to “hold,” Morgan Stanley trimmed its price target to $24 (from $45), and Telsey cut its target to $35 while keeping an outperform stance. These moves reduce near‑term upside expectations and can amplify selling. Benzinga

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.